Business Description
Shilpa Medicare Ltd
ISIN : INE790G01031
Total Employee Number:
998Compare
Compare
Traded in other countries / regions
530549.India IPO Date
1995-06-21Description
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 1.39 | |||||
Interest Coverage | 4.37 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.35 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EBITDA Growth Rate | 61.1 | |||||
3-Year FCF Growth Rate | 18.6 | |||||
3-Year Book Growth Rate | 8.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 32.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -31.23 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.04 | |||||
9-Day RSI | 56.22 | |||||
14-Day RSI | 59.39 | |||||
3-1 Month Momentum % | 39.19 | |||||
6-1 Month Momentum % | 95.58 | |||||
12-1 Month Momentum % | 23.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 306.42 | |||||
Days Sales Outstanding | 109.68 | |||||
Days Payable | 106.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.08 | |||||
Dividend Payout Ratio | 0.05 | |||||
3-Year Dividend Growth Rate | -3.1 | |||||
Forward Dividend Yield % | 0.08 | |||||
5-Year Yield-on-Cost % | 0.08 | |||||
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | -0.64 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.07 | |||||
Operating Margin % | 21.53 | |||||
Net Margin % | 15.82 | |||||
EBITDA Margin % | 30.81 | |||||
FCF Margin % | -1.85 | |||||
OCF Margin % | 22.25 | |||||
ROE % | 9.86 | |||||
ROA % | 6.94 | |||||
ROIC % | 8.33 | |||||
3-Year ROIIC % | 40.95 | |||||
ROC (Joel Greenblatt) % | 15.69 | |||||
ROCE % | 13.56 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.39 | |||||
Forward PE Ratio | 28.6 | |||||
PE Ratio without NRI | 57.66 | |||||
Shiller PE Ratio | 84.11 | |||||
Price-to-Owner-Earnings | 49.63 | |||||
PEG Ratio | 4.58 | |||||
PS Ratio | 7.81 | |||||
PB Ratio | 4.68 | |||||
Price-to-Tangible-Book | 6.39 | |||||
Price-to-Operating-Cash-Flow | 35.41 | |||||
EV-to-EBIT | 34.19 | |||||
EV-to-EBITDA | 26.77 | |||||
EV-to-Forward-EBITDA | 23.74 | |||||
EV-to-Revenue | 8.25 | |||||
EV-to-Forward-Revenue | 6.14 | |||||
EV-to-FCF | -445.89 | |||||
Price-to-GF-Value | 1.6 | |||||
Price-to-Projected-FCF | 23.15 | |||||
Price-to-DCF (Earnings Based) | 6.21 | |||||
Price-to-Median-PS-Value | 1.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.07 | |||||
Price-to-Graham-Number | 4.05 | |||||
Earnings Yield (Greenblatt) % | 2.92 | |||||
FCF Yield % | -0.23 | |||||
Forward Rate of Return (Yacktman) % | 11.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shilpa Medicare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 15,381.429 | ||
| EPS (TTM) (₹) | 11.39 | ||
| Beta | 0.7313 | ||
| 3-Year Sharpe Ratio | 1.15 | ||
| 3-Year Sortino Ratio | 2.6 | ||
| Volatility % | 42.37 | ||
| 14-Day RSI | 59.39 | ||
| 14-Day ATR (₹) | 24.493176 | ||
| 20-Day SMA (₹) | 599.355 | ||
| 12-1 Month Momentum % | 23.7 | ||
| 52-Week Range (₹) | 260 - 650 | ||
| Shares Outstanding (Mil) | 195.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shilpa Medicare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shilpa Medicare Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2025-10-03 | 390.50 (+0.55%) | ||
| INR 0.500000 Cash Dividend | 2025-09-17 | 413.13 (-0.31%) | ||
| 2:1 Stock Split | 2015-11-06 | 236.66 (-1.12%) | ||
| 1.5:1 Stock Split | 2013-07-16 | 46.31 (-2.27%) | ||
| 5:1 Stock Split | 2007-09-28 | 19.57 (+5.00%) |
Show
Entries
Shilpa Medicare Ltd Frequently Asked Questions
What is Shilpa Medicare Ltd(BOM:530549)'s stock price today?
The current price of BOM:530549 is ₹619.55. The 52 week high of BOM:530549 is ₹650.00 and 52 week low is ₹260.00.
When is next earnings date of Shilpa Medicare Ltd(BOM:530549)?
The next earnings date of Shilpa Medicare Ltd(BOM:530549) is .
Does Shilpa Medicare Ltd(BOM:530549) pay dividends? If so, how much?
The Dividend Yield %  of Shilpa Medicare Ltd(BOM:530549) is 0.08% (As of Today), Highest Dividend Payout Ratio of Shilpa Medicare Ltd(BOM:530549) was 0.16. The lowest was 0.04. And the median was 0.06. The  Forward Dividend Yield % of Shilpa Medicare Ltd(BOM:530549) is 0.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Shilpa Medicare Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers